Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNAseq of prostate cancer cells (PC3 and DU145) treated with 2.5 uM pentamidine or vehicle

ABSTRACT: RNAseq of prostate cancer cells (PC3 and DU145) treated with 2.5 uM pentamidine or vehicle

PROVIDER: PRJNA548765 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9292580_1.fastq.gz	Fastqsanger.gz
	SRR9292580_2.fastq.gz	Fastqsanger.gz
	SRR9292581_1.fastq.gz	Fastqsanger.gz
	SRR9292581_2.fastq.gz	Fastqsanger.gz
	SRR9292582_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

RNAseq of prostate cancer cells (PC3 and DU145) treated with 2.5 uM pentamidine or vehicle

Project description:To uncover the mechanism underlying the effect of pentamidine on prostate cancer cells, we performed RNA sequencing (RNA-seq) to compare the transcriptional difference between pentamidine- and vehicle-treated prostate cancer cells (PC3 and DU145 cells).

2019-06-14 | GSE132693 | GEO

Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes

Project description:The goals of this study is to find effect of overexpression-TRIB1 to prostate cancer cell (PC3 and DU145).

2019-01-08 | GSE124733 | GEO

Gene expression profiling from human prostate cancer PC3 or DU145 cells with control or ESS2 knockdown.

Project description:PC3 and DU145 cells stably transduced with control or ESS2 shRNA were established. Total RNA was isolated from 5x 10^6 cells of each

2023-08-09 | GSE173998 | GEO

Microarray analysis of Du145, PC3 and LNCaP human prostate cancer cell lines

Project description:Study aimed at evaluating differences in Du145, PC3 and LNCaP human prostate cancer cells treated with ATX-101 and docetaxel for 24h.

2017-12-31 | E-MTAB-4858 | biostudies-arrayexpress

Study of matrix proteins synthesized by DU145 and PC3 prostate cancer cells alone or in co-culture with prostate-derived fibroblasts.

Project description:Tumor microenvironment or stroma has the potency to regulate the behavior of malignant cells. Fibroblast-like cells are abundant in tumor stroma and they are also responsible for the synthesis of many extracellular matrix components. Fibroblast–cancer cell interplay can modify the functions of both cell types. We applied mass spectrometry and proteomics to unveil the matrisome in 3D spheroids formed by DU145 prostate cancer cells, PC3 prostate cancer cells or prostate derived fibroblasts. Similarly DU145/fibroblast and PC3/fibroblast co-culture spheroids were also analyzed. Western Blotting and immunofluorescence were used to confirm the presence of specific proteins in spheroids. Cancer dissemination was studied by utilizing "out of spheroids" migration and invasion assays. In the spheroid model cancer cell–fibroblast interplay caused remarkable changes in extracellular matrix and accelerated the invasion of DU145 cells. Fibroblasts produced structural matrix proteins, growth factors and matrix metalloproteinases. In cancer cell/fibroblast co-cultures basement membrane components, including laminins (3, 5, 2, 3), heparan sulphate proteoglycan (HSPG2 gene product), and collagen XVIII accumulated in a prominent manner when compared to spheroids that contained fibroblasts or cancer cells only. Furthermore, collagen XVIII was intensively processed to different endostatin isoforms by cancer cell derived cathepsin L. To sum up, fibroblasts can promote carcinoma cell dissemination by several different mechanisms. Extracellular matrix and basement membrane proteins provide attachment sites for cell locomotion promoting adhesion receptors. Growth factors and metalloproteinases are known to accelerate cell invasion. Additionally, cancer cell–fibroblast interplay generates biologically active fragments of basement membrane proteins, such as endostatin.

2020-05-04 | PXD016882 | Pride

RNA-seq control (sgNT) and TLE3KO (sgTLE3) cells treated with 10 uM enzalutamide or vehicle

Project description:To investigate the transcriptional consequences of TLE3 loss in the presence/absence of AR inhibitor enzalutamide in prostate cancer cells, the transcriptomes of WT and TLE3KO cells treated with vehicle or enzalutamide (10 uM) were compared. .

2020-01-27 | GSE130246 | GEO

Lamming PC3 human TMT proteomics

Project description:PC3 cells were grown in 10% DMEM with FBS and treated with vehicle (DMSO), 100 nM rapamycin, or 100 nM DL001 for 24 hours

2019-03-20 | MSV000083602 | MassIVE

Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes

Project description:Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes

| PRJNA513295 | ENA

Transcription profiling of human bronchial epithelial cells treated with vehicle (control), VOSO4 (V, 50 uM) or ZnSO4 (Zn, 50 uM) for 4 hours.

Project description:Human bronchial epithelial cells were treated with vehicle (control), VOSO4 (V, 50 uM) or ZnSO4 (Zn, 50 uM) for 4 hours.

2007-08-25 | E-GEOD-2111 | biostudies-arrayexpress

Gene expression profiling from human prostate cancer PC3 or DU145 cells with control or ESS2 knockdown.

Project description:Gene expression profiling from human prostate cancer PC3 or DU145 cells with control or ESS2 knockdown.